Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 001
mi
from
Columbus, OH
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 001
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site
mi
from
Oklahoma City, OK
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 003
mi
from
Tulsa, OK
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 003
mi
from
Tulsa, OK
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 053
mi
from
Gresham, OR
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 053
mi
from
Gresham, OR
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 133
mi
from
Portland, OR
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 133
mi
from
Portland, OR
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 1805
mi
from
Altoona, PA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 1805
mi
from
Altoona, PA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 131
mi
from
McMurray, PA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 131
mi
from
McMurray, PA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 010
mi
from
Media, PA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 010
mi
from
Media, PA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative site 066
mi
from
Charleston, SC
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative site 066
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 128
mi
from
Sioux Falls, SD
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 128
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site
mi
from
Memphis, TN
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 057
mi
from
Nashville, TN
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 057
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 51
mi
from
Houston, TX
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 51
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 027
mi
from
Houston, TX
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 027
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 014
mi
from
Clinton, UT
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 014
mi
from
Clinton, UT
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 029
mi
from
Salt Lake City, UT
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 029
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 064
mi
from
Charlottesville, VA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 064
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative site 031
mi
from
Norfolk, VA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative site 031
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 124
mi
from
Roanoke, VA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 124
mi
from
Roanoke, VA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 014
mi
from
Bothell, WA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 014
mi
from
Bothell, WA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 121
mi
from
Seattle, WA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 121
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 119
mi
from
Charleston, WV
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 119
mi
from
Charleston, WV
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 007
mi
from
Middleton, WI
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 007
mi
from
Middleton, WI
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
Forest Investigative Site 138
mi
from
Milwaukee, WI
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 138
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Drug Discrimination in Methadone-Maintained Humans Study 3
Drug Discrimination in Methadone-Maintained Humans Study 3
Status: Enrolling
Updated:  9/4/2012
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Drug Discrimination in Methadone-Maintained Humans Study 3
Drug Discrimination in Methadone-Maintained Humans Study 3
Status: Enrolling
Updated: 9/4/2012
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Intervention for Anxiety After Falls
Intervention for Disabling Anxiety in Older Adults Injured by Falls
Status: Enrolling
Updated:  9/4/2012
Weill Medical College of Cornell University
mi
from
New York, NY
Intervention for Anxiety After Falls
Intervention for Disabling Anxiety in Older Adults Injured by Falls
Status: Enrolling
Updated: 9/4/2012
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Status: Enrolling
Updated:  9/4/2012
Collinge and Associates
mi
from
Kittery, ME
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Status: Enrolling
Updated: 9/4/2012
Collinge and Associates
mi
from
Kittery, ME
Click here to add this to my saved trials
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Status: Enrolling
Updated:  9/4/2012
Collinge and Associates
mi
from
Eugene, OR
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Status: Enrolling
Updated: 9/4/2012
Collinge and Associates
mi
from
Eugene, OR
Click here to add this to my saved trials
Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.
A Double Blind Trial Of Divalproex Sodium For Affective Lability And Alcohol Use Following Traumatic Brain Injury
Status: Enrolling
Updated:  9/6/2012
Denver Veterans Affairs Medical Center
mi
from
Denver, CO
Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.
A Double Blind Trial Of Divalproex Sodium For Affective Lability And Alcohol Use Following Traumatic Brain Injury
Status: Enrolling
Updated: 9/6/2012
Denver Veterans Affairs Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated:  9/6/2012
Veteran's Affairs Medical Center
mi
from
Denver, CO
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated: 9/6/2012
Veteran's Affairs Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Status: Enrolling
Updated:  9/10/2012
University of California, Irvine Medical Center
mi
from
Orange, CA
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Status: Enrolling
Updated: 9/10/2012
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
The Use of D-Cycloserine to Augment CBT for Pediatric OCD
The Use of D-Cycloserine to Augment Intensive Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder
Status: Enrolling
Updated:  9/13/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
The Use of D-Cycloserine to Augment CBT for Pediatric OCD
The Use of D-Cycloserine to Augment Intensive Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder
Status: Enrolling
Updated: 9/13/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children
Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children: a Randomized Clinical Trial
Status: Enrolling
Updated:  9/14/2012
National Institute of Mental Health (NIMH)
mi
from
Bethesda, MD
Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children
Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children: a Randomized Clinical Trial
Status: Enrolling
Updated: 9/14/2012
National Institute of Mental Health (NIMH)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Open-Label Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Status: Enrolling
Updated:  9/18/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Open-Label Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Status: Enrolling
Updated: 9/18/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
Status: Enrolling
Updated:  10/1/2012
University of Connecticut Health Center
mi
from
Farmington, CT
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
Status: Enrolling
Updated: 10/1/2012
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Neuropsychiatry Clinic and Research Center
mi
from
Bullhead City, AZ
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Neuropsychiatry Clinic and Research Center
mi
from
Bullhead City, AZ
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Shanti Clinical Trials
mi
from
Colton, CA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Shanti Clinical Trials
mi
from
Colton, CA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Sun Valley Research Center
mi
from
Imperial, CA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Sun Valley Research Center
mi
from
Imperial, CA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
South Coast Clinical Trials, Inc.
mi
from
Anaheim-Santa Ana-Garden Grove, CA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
South Coast Clinical Trials, Inc.
mi
from
Anaheim-Santa Ana-Garden Grove, CA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Aurora Mental Health Center
mi
from
Aurora, CO
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Aurora Mental Health Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
LifeStream Behavioral Center, Inc.
mi
from
Leesburg, FL
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
LifeStream Behavioral Center, Inc.
mi
from
Leesburg, FL
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
APF Research
mi
from
Miami, FL
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
APF Research
mi
from
Miami, FL
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
River Edge Behavioral Health Center
mi
from
Macon, GA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
River Edge Behavioral Health Center
mi
from
Macon, GA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Human Service Center (Fayette Companies)
mi
from
Peoria, IL
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Human Service Center (Fayette Companies)
mi
from
Peoria, IL
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Centerstone-Indiana Centerstone Research Institute
mi
from
Bloomington, IN
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Centerstone-Indiana Centerstone Research Institute
mi
from
Bloomington, IN
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Medical Development Centers LLC (Baton Rouge)
mi
from
Baton Rouge, LA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Medical Development Centers LLC (Baton Rouge)
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Medical Development Centers LLC (Opelousas)
mi
from
Opelousas, LA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Medical Development Centers LLC (Opelousas)
mi
from
Opelousas, LA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
OCCMHA/Community Network Services, Inc.: Oakland County Community Mental Health Authority
mi
from
Farmington Hills, MI
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
OCCMHA/Community Network Services, Inc.: Oakland County Community Mental Health Authority
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Cherry Street Health Services
mi
from
Grand Rapids, MI
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Cherry Street Health Services
mi
from
Grand Rapids, MI
Click here to add this to my saved trials